CliffBio
small molecule

TAYTULLA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

Drug detail

Brand nameTAYTULLA
Active ingredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Strength0.02MG;1MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2013
Marketing statusRX

More from ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TAYTULLA patent cliff — loss of exclusivity — | CliffBio